Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp142 | Cell biology: osteoblasts and bone formation | ECTS2014

Cell attachment and proliferation of bone marrow-derived osteoblast on zirconia of various surface treatment

Lee Heesu , Pae Ahran , Noh Kwantae , Woo Yi-Hyung

This study was performed to characterize the effects of calcium phosphate coated and hydroxyapatite coated zirconia compared to smooth surfaced zirconia with bone marrow-derived osteoblast culture.Bone marrow-derived osteoblasts were cultured on i) smooth zirconia, ii) zirconia coated with calcium phosphate (CaP), and iii) zirconia coated with hydroxyapatite (HA). The tetrazolium-based colorimetric assay (MTT test) was used for examining the attachment o...

ba0005p100 | Cancer and bone: basic, translational and clinical | ECTS2016

The clinicopathological implication of GNAS in ewing sarcoma

Noh Byeong-Joo , Sung Ji-Youn , Kim Youn Wha , Araujo Eduardo Santini , Kalil Ricardo Karam , Jung Woon-Won , Kim Hyun-Sook , Park Yong-Koo

The objective of our study is to determine whether GNAS expression correlates with pathognomonic signs by analyzing mutations, methylation status, and G-protein α subunit (Gsα) expression of GNAS (guanine nucleotide binding protein/α stimulating) gene in Ewing Sarcoma (ES).Formalin-fixed paraffin-embedded (FFPE) tissue samples from 77 patients with primary ES were obtained in Korea, Argentina, and Brazil, and w...

ba0005p104 | Cancer and bone: basic, translational and clinical | ECTS2016

Long-term effect of aromatase inhibitor on bone mineral density, trabecular bone score, and hip geometry in postmenopausal women with primary breast cancer

Hong A Ram , Kim Jung Hee , Lee Kyung-Hun , Kim Tae Yong , Im Seock-Ah , Kim Tae-You , Moon Hyung-Gon , Han Wonshik , Noh Dong-Young , Kim Sang Wan , Shin Chan Soo

Background: Aromatase inhibitors (AIs) increase the risk of fracture in patients with breast cancer. Therefore, we aimed to evaluate the long-term effects of AIs on bone health in postmenopausal women with primary breast cancer.Patients and methods: We performed a retrospective longitudinal observational study in patients with breast cancer who were treated by AIs for ≧3 years (baseline T-score >–2.5). Patients with previous anti-osteoporosis...